Evidence-based toxicology: Strait is the gate, but the road is worth taking

Altex

Volumn 30, Issue 1, 2013, Pages 67-73

  Silbergeld, Ellen ^a   Scherer, Roberta W ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Evidence based medicine health care; Evidence based toxicology; Systematic reviews

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DECISION MAKING; EVIDENCE BASED MEDICINE; EVIDENCE BASED TOXICOLOGY; EXPERIMENTAL ANIMAL; GOOD LABORATORY PRACTICE; HEALTH CARE; HUMAN; METHODOLOGY; NONHUMAN; PRACTICE GUIDELINE; SYSTEMATIC REVIEW (TOPIC); TOXICOLOGY;

EID: 84875897923     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.1.067     Document Type: Article

References (44)

1. AMS (2007). Identifying the Environmental Causes of Disease: How Should We Decide What to Believe and When to Take Action. London, UK: The Academy of Medical Sciences.
2. Axelrad, D. A., Bellinger, D. C., Ryan, L. M., et al. (2007). Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect 115, 609-615. (Pubitemid 46585535)
3. Beronius, A., Rudén, C., Håkansson, H., and Hanberg, A. (2010). Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A. Reprod Toxicol 29, 132-46.
4. Blair, A., Burg, J., Foran, J., et al. (1995). Guidelines for application of meta-Analysis in environmental epidemiology. ISLI Risk Science Institute. Regul Toxicol Pharmacol 22, 189-197.
5. Chalmers, I. (2005). Academia's failure to support systematic reviews. Lancet 365, 469. (Pubitemid 40215722)
6. Chou, R. and Helfand, M. (2005). Challenges in systematic reviews that assess treatment harms. Ann Intern Med 142, 1090-1099. (Pubitemid 40847712)
7. Crofton, K. M., Makris, S. L., Sette, W. F., et al. (2004). A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicol Teratol 26, 345-352. (Pubitemid 38534467)
8. Daston, G. P., Cook, J. C., and Kavlock, R. J. (2003). Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74, 245-252. (Pubitemid 36958292)
9. Dickersin, K., Scherer, R., and Lefebvre, C. (1994). Identifying relevant studies for systematic reviews. BMJ 309, 1286-1291. (Pubitemid 24340510)
10. Dickersin, K. and Manheimer, E. (1998). The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials. Clin Obstet Gynecol 41, 315-331. (Pubitemid 28287824)
11. Duong, A., Steinmaus, C., McHale, C. M., et al. (2011). Reproductive and developmental toxicity of formaldehyde: a systematic review. Mutat Res 728, 118-138.
12. EEA (2001). Late Lessons from Early Warnings: The Precautionary Principle 1896-2000. Copenhagen, Denmark: European Environment Agency.
13. Feinstein, A. R. (1995). Meta-Analysis: statistical alchemy for the 21st century. J Clin Epidemiol 48, 71-79.
14. Flower, A., Lewith, G. T., and Little, P. (2007). Seeking an oracle: using the Delphi process to develop practice guidelines for the treatment of endometriosis with Chinese herbal medicine. J Altern Complement Med 13, 969-976. (Pubitemid 350208878)
15. Gatchel, R. J. and McGeary, D. (2002). Cochrane collaborationbased reviews of health-care interventions: are they unequivocal and valid scientifically, or simply nihilistic? Spine J 2, 315-319.
16. Griesinger, C., Hoffmann, S., Kinsner, A., et al. (2009). Special issue: Evidence-based toxicology (EBT). Preface. Hum Exp Toxicol 28, 83-86.
17. Grimshaw, J. M., Santesso, N., Cumpston, M., et al. (2006). Knowledge for knowledge translation: the role of the Cochrane Collaboration. J Contin Educ Health Prof 26, 55-62.
18. Guzelian, P. S., Victoroff, M. S., Halmes, N. C., et al. (2005). Evidence-based toxicology: a comprehensive framework for causation. Hum Exp Toxicol 24, 161-201. (Pubitemid 40778683)
19. Hartung, T. (2010). Evidence-based toxicology -The toolbox of validation for the 21st century? ALTEX 27, 253-263.
20. Hoffmann, S. and Hartung, T. (2006). Toward an evidencebased toxicology. Hum Exp Toxicol 25, 497-513.
21. IARC (2006). Inorganic and Organic Lead Compounds, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer.
22. Judson, R., Kavlock, R, Martin, M., et al. (2013). Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX 30, 51-66.
23. Longnecker, M. P., Berlin, J. A., Orza, M. J., et al. (1988). A meta-Analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260, 652-656.
24. Maull, E. A., Ahsan, H., Edwards, J., et al. (2012). Evaluation of the association between arsenic and diabetes: A National Toxicology Program Workshop Review. Environ Health Perspect. http://dx.doi.org/10.1289/ehp.1104579
25. Moher, D., Jadad, A. R., and Tugwell, P. (1996). Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 12, 195-208. (Pubitemid 26195520)
26. Mulrow, C. D. (1987). The medical review article: state of the science. Ann Intern Med 106, 485-488.
27. Myers, J. P., vom Saal, F. S., Akingbemi, B. T., et al. (2009). Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect 117, 309-315.
28. Navas-Acien, A., Sharrett, A. R., Silbergeld, E. K., et al. (2005). Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 162, 1037-1049. (Pubitemid 41746616)
29. Navas-Acien, A., Silbergeld, E. K., Streeter, R. A., et al. (2006). Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 114, 641-648.
30. Navas-Acien, A., Guallar, E., Silbergeld, E. K., et al. (2007). Lead exposure and cardiovascular disease -A systematic review. Environ Health Perspect 115, 472-482. (Pubitemid 46554449)
31. NRC -National Research Council (1994). Science and Judgment in Risk Assessment. Washington, DC: National Academies Press.
32. NRC (2001). Arsenic in Drinking Water. Washington: NAS Press.
33. NRC (2007). Toxicity Testing in the 21st Century. Washington, DC: National Academies Press.
34. NTP -National Toxicology Program (2011). NTP Monograph on Health Effects of Low Level Lead, NTP, NIEHS, USDHHS, draft October 14, 2011. http://ntp.niehs.nih.gov/NTP/ohat/Lead/ DraftNTPMonographonHealthEffectsofLowLevelLead. pdf (downloaded April 4, 2012).
35. Oxman, A. D. and Guyatt, G. H. (1988). Guidelines for reading literature reviews. CMAJ 138, 697-703.
36. Reuter, U., Heinrich-Hirsch, B., Hellwig, J., et al. (2003). Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/ developmental toxicity screening test). Regul Toxicol Pharmacol 38, 17-26. (Pubitemid 36870866)
37. Rovida, C. and Hartung, T. (2009). Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals -A report by the transatlantic think tank for toxicology (t4). ALTEX 26, 187-208.
38. Sackett, D. L., Rosenberg, W. M., Gray, J. A., et al. (1996). Evidence based medicine: what it is and what it isn't. BMJ 312, 71-72.
39. Silbergeld, E. K. (2003). Facilitative mechanisms of lead as a carcinogen. Mutat Res 533, 121-133. (Pubitemid 37487864)
40. Silbergeld, E., Lerman, S., and Hushka, L. (2004). Ethics. Human health research ethics. Science 305, 949.
41. Silbergeld, E. (2009). 4.2 Applying an evidence-based approach: arsenic as a health risk. Hum Exp Toxicol 28, 127-129.
42. Stephens, M., Andersen, M., Becker, R. A., et al. (2013). Evidence-based toxicology for the 21st century: Opportunities and challenges. ALTEX 30, 74-103.
43. Straif, K., Stayner, L., Demers, P. A., et al. (2012). Use of metaanalyses by IARC working groups. Environ Health Perspect 120. doi:10.1289/ehp.1205397
44. Williams, D. D. and Garner, J. (2002). The case against 'the evidence': a different perspective on evidence-based medicine. Br J Psychiatry 180, 8-12. (Pubitemid 34093618)